What is the Ashar formula for determining balloon size in Balloon Mitral Valvuloplasty (BMV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ashar Formula for Balloon Size in Balloon Mitral Valvuloplasty (BMV)

The Ashar formula for determining balloon size in Balloon Mitral Valvuloplasty (BMV) uses the echocardiographic measurement of the maximal intercommissural diameter as the reference for balloon sizing, which results in better outcomes with larger final mitral valve areas and significantly lower rates of iatrogenic mitral regurgitation compared to traditional height-based sizing methods.

Understanding the Ashar Formula Approach

The Ashar formula represents an echocardiography-guided approach to balloon sizing in BMV that differs from the conventional height-based formula. This approach involves:

  1. Measuring the maximal mitral commissural diameter at a fully opened state during diastole using transthoracic echocardiography 1
  2. Using this measurement directly as the reference for balloon size selection
  3. This typically results in smaller balloon sizes than the traditional height-based formula (mean 26mm vs 28mm) 1

Comparison with Traditional Height-Based Sizing

The traditional height-based formula has been the standard approach for BMV balloon sizing, but research shows that the Ashar formula offers several advantages:

  • Randomized controlled trials demonstrate that echocardiographic intercommissural diameter-based sizing leads to:
    • Significantly larger final mitral valve areas (1.5 ± 0.2 cm² vs 1.4 ± 0.2 cm²) 2
    • Lower rates of new or aggravated mitral regurgitation (11.5% vs 29.3%) 2
    • Better procedural outcomes with fewer complications 1, 2

Clinical Implementation of the Ashar Formula

When using the Ashar formula for BMV:

  1. Perform transthoracic echocardiography to measure the maximal commissural diameter during diastole
  2. Use this measurement directly to determine the appropriate balloon size
  3. This patient-specific approach accounts for individual anatomical variations that height-based formulas cannot capture

Balloon Sizing Considerations

Proper balloon sizing is critical for optimal outcomes in BMV:

  • Oversized balloons increase the risk of mitral regurgitation and complications
  • Undersized balloons may result in suboptimal valve area improvement
  • The Ashar formula typically results in smaller balloon sizes (mean 24.5 ± 1.03 mm) compared to height-based formulas (mean 26.4 ± 0.92 mm) 2

Procedural Outcomes and Safety

The evidence strongly supports using the Ashar formula for balloon sizing:

  • Echocardiographic commissural diameter-based sizing is associated with:
    • Better immediate hemodynamic results
    • Lower complication rates
    • Significant decrease in the rate and severity of iatrogenic mitral regurgitation 2
    • Acceptable increase in mitral valve area 2

Common Pitfalls and Caveats

  • Ensure accurate measurement of the intercommissural diameter during full diastolic opening
  • Consider valve morphology, calcification, and subvalvular apparatus when applying the formula
  • Remember that even with optimal balloon sizing, outcomes may be affected by valve anatomy and pathology
  • The formula should be used as part of a comprehensive assessment that includes evaluation of valve pliability and calcification

The Ashar formula represents a significant advancement in BMV technique by providing a patient-specific, anatomically-guided approach to balloon sizing that improves outcomes and reduces complications compared to traditional height-based methods.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.